Purchase Order 75N95023P00644
Award Date 8/28/23
Potential Completion Date 9/27/23
Potential Value $12K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St Peters, MO 63304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Eurofins Panlabs, Inc. was awarded a firm fixed-price purchase order valued at approximately $4,000 by the National Institutes of Health's National Institute of Child Health and Human Development to provide laboratory testing services from September through December 2014. As a division of Eurofins Panlabs, Inc. located in Redmond, Washington, the contractor will support the NIH/NICHD's research efforts through analysis and certification activities under contract number 1165243 during the...
- This is a firm-fixed-price purchase order worth $20,979.04 awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract is for binding studies with a period of performance through August 10, 2024. Eurofins Panlabs has received numerous federal contract awards from agencies like NIH, EPA, FDA, and VA to provide...
- This is a $140,748 firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Eurofins Panlabs, Inc. for receptor binding and predictive toxicology services. The work will be performed in Weldon Spring, Missouri and is not associated with any set-aside designation. Eurofins Panlabs, Inc. is a foreign-owned for-profit contract research organization that has previously provided analytical chemistry,...
- Eurofins Panlabs, Inc. was awarded a $1,000 firm fixed price delivery order against the CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract with the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences. The delivery order is for a contract kickoff conference call to provide Cro support services in support of the National Center for Advancing Translational Sciences' medicinal chemistry program...
- This is a $45,365 firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract is for the analysis of three compounds in a panel of 50 customized cancer cell lines over a three-month period. The work aims to evaluate the effects of the compounds on cell proliferation, cell death, caspase activity, and...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Delivery Order contract to Eurofins Panlabs, Inc. on August 14, 2018. The $506,922.00 Firm Fixed Price contract is for lead optimization screening assays to evaluate absorption, distribution, metabolism, excretion (ADME), safety, and pharmacokinetic (PK) properties. This Delivery Order falls under the parent Nonclinical Services for Development...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Task Order E06 "Custom Screening Assays for Metabolic Stability and Peptidase Selectivity" to Eurofins Panlabs, Inc. for $359,026.82 on a firm fixed price basis. This task order is part of the Nonclinical Services for Development of Interventional Agents indefinite delivery/indefinite quantity (IDIQ) contract. Eurofins Panlabs, Inc. is a contract...
- This is a $458,102 firm-fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to Eurofins Panlabs, Inc. The delivery order is for "Lead Optimization Screening Assays for ADMET and Safety Profiling" and was issued under the "Nonclinical Services for Development of Interventional Agents" indefinite delivery/indefinite quantity (IDIQ) contract. The delivery...
- This task order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Nonclinical Services for Development of Interventional Agents. The task order, valued at $102,981.15, is for "Lead Optimization Screening Assays for Safety Profiling" and has a total potential value of $137,856.75. Eurofins Panlabs, a foreign-owned for-profit...
- This is a $207,360 firm fixed price delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. to provide non-GLP standard, initial profiling of lead compounds in rodent pharmacokinetics screening assays. The work supports the selection of promising lead series and in vitro-in vivo correlation data for the development of interventional agents. This delivery order is under the NIH's Nonclinical...
Eurofins Panlabs, Inc. has been awarded a $12,467.70 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide a CNS panel for safety screening. The work will be performed in Weldon Spring, Missouri over a period of one month concluding in late September 2023. No set aside designation or subcontractors are indicated. This award is likely in support of the NIH's efforts to translate basic scientific discovery into clinical applications through screening of potential drug candidates.
Generated 12/24/23, 4:06 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 8/25/23 |